{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T12:43:57Z","timestamp":1726404237026},"reference-count":48,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013452","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T03:24:31Z","timestamp":1571714671000},"update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Topical treatments and photodynamic therapy for actinic keratosis of the face and scalp"],"prefix":"10.1002","author":[{"given":"Kelly","family":"Foley","sequence":"first","affiliation":[{"name":"Mediprobe Research Inc.; 645 Windermere Road London ON Canada N5X 2P1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya K","family":"Gupta","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc.; 645 Windermere Road London ON Canada N5X 2P1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Martin","sequence":"additional","affiliation":[{"name":"Dr. George Martin Dermatology Associates; 41 East Lipoa St Suite 21 Kihei Hawaii USA 96753"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A","family":"Tweed","sequence":"additional","affiliation":[{"name":"The University of Nottingham; c\/o Cochrane Skin Group; King's Meadow Campus Lenton Lane Nottingham UK NG7 2NR"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmer","family":"Villanueva","sequence":"additional","affiliation":[{"name":"Xi'an Jiaotong-Liverpool University; Department of Public Health; 111 Ren'ai Road, Dushu Lake Higher Education Town Suzhou Industrial Park Suzhou Jiangsu China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessie","family":"Carviel","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc.; 645 Windermere Road London ON Canada N5X 2P1"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD013452-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1124\/mol.61.1.7","article-title":"Diclofenac antagonizes peroxisome proliferator-activated receptor-gamma signaling","volume":"61","author":"Adamson","year":"2002","journal-title":"Molecular Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD013452-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.2042-7158.1995.tb05820.x","article-title":"Angiostasis and vascular regression in chronic granulomatous inflammation induced by diclofenac in combination with hyaluronan in mice","volume":"47","author":"Alam","year":"1995","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD013452-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1365-2133.2002.04720.x","article-title":"Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans","volume":"146","author":"Berhane","year":"2002","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD013452-BIB0004|cit4","first-page":"167","article-title":"Mechanisms of action of new treatment modalities for actinic keratosis","volume":"5","author":"Berman","year":"2006","journal-title":"Journal of Drugs in Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD013452-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1468-3083.2004.01180.x","article-title":"Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin","volume":"19","author":"Brown","year":"2005","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"4","key":"10.1002\/14651858.CD013452-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4103\/0253-7613.161249","article-title":"Imiquimod - Its role in the treatment of cutaneous malignancies","volume":"47","author":"Bubna","year":"2015","journal-title":"Indian Journal of Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD013452-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/bjd.12591","article-title":"Reliability of quantification measures of actinic keratosis","volume":"169","author":"Chen","year":"2013","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD013452-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13555-015-0070-9","article-title":"Primary care review of actinic keratosis and its therapeutic options: a global perspective","volume":"5","author":"Chetty","year":"2015","journal-title":"Dermatology and Therapy"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD013452-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1067\/mjd.2000.103344","article-title":"Histopathology of incipient intraepidermal squamous cell carcinoma (\"actinic keratosis\")","volume":"42","author":"Cockerell","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD013452-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1524-4725.1996.tb00565.x","article-title":"Dermabrasion for prophylaxis and treatment of actinic keratoses","volume":"22","author":"Coleman","year":"1996","journal-title":"Dermatologic Surgery"},{"issue":"2","key":"10.1002\/14651858.CD013452-BIB0011|cit11","first-page":"29","article-title":"How to treat actinic keratosis? An update","volume":"9","author":"Costa","year":"2015","journal-title":"Journal Dermatology Case Reports"},{"issue":"11","key":"10.1002\/14651858.CD013452-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Actinic keratoses: natural history and risk of malignant transformation in the Veteran Affairs Topical Tretinoin Chemoprevention Trial","volume":"115","author":"Criscione","year":"2009","journal-title":"Cancer"},{"issue":"5","key":"10.1002\/14651858.CD013452-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/1203475417708166","article-title":"Comparison of the treatment guidelines for actinic keratosis: a critical appraisal and review","volume":"21","author":"Fleming","year":"2017","journal-title":"Journal of Cutaneous Medicine and Surgery"},{"issue":"9","key":"10.1002\/14651858.CD013452-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1158\/1535-7163.MCT-15-0023-T","article-title":"Ingenol mebutate signals via PKC\/MEK\/ERK in keratinocytes and induces interleukin decoy receptors IL1R2 and IL13RA2","volume":"14","author":"Freiberger","year":"2015","journal-title":"Molecular Cancer Therapy"},{"issue":"5","key":"10.1002\/14651858.CD013452-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-4362.1994.tb01065.x","article-title":"Proliferative actinic keratosis","volume":"33","author":"Goldberg","year":"1994","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD013452-BIB0016|cit16","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"issue":"2","key":"10.1002\/14651858.CD013452-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/bjd.12343","article-title":"Network meta-analysis of the outcome \u2018participant complete clearance\u2019 in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review","volume":"169","author":"Gupta","year":"2013","journal-title":"British Journal of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD013452-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1001\/archderm.142.8.976","article-title":"Facial resurfacing for nonmelanoma skin cancer prophylaxis","volume":"142","author":"Hantash","year":"2006","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD013452-BIB0019|cit19","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"12","key":"10.1002\/14651858.CD013452-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1039\/b705461k","article-title":"Milestones in the development of photodynamic therapy and fluorescence diagnosis","volume":"6","author":"Juzeniene","year":"2007","journal-title":"Photochemical and Photobiological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD013452-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"e0153975","DOI":"10.1371\/journal.pone.0153975","article-title":"IL-1 contributes to the anti-cancer efficacy of ingenol mebutate","volume":"11","author":"Le","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1002\/14651858.CD013452-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-Fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"10.1002\/14651858.CD013452-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0030-6665(20)30864-1","article-title":"Actinic keratosis: a premalignant skin lesion","volume":"26","author":"Marks","year":"1993","journal-title":"Otolaryngologic Clinics of North America"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD013452-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.jaad.2012.09.050","article-title":"Clinical findings using ingenol mebutate gel to treat actinic keratoses","volume":"68","author":"Martin","year":"2013","journal-title":"Journal American Academy Dermatology"},{"key":"10.1002\/14651858.CD013452-BIB0025|cit25","first-page":"1677","article-title":"Actinic keratosis, basal cell carcinoma, and squamous cell carcinoma","volume-title":"Dermatology","volume":"2","author":"Miller","year":"2003"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD013452-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1067\/mjd.2000.103343","article-title":"Clinical presentation of actinic keratoses and squamous cell carcinoma","volume":"42","author":"Moy","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD013452-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.bjc.6602331","article-title":"Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid","volume":"92","author":"Niedre","year":"2005","journal-title":"British Journal of Cancer"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD013452-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0190-9622(91)70113-G","article-title":"A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck","volume":"24","author":"Olsen","year":"1991","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD013452-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1524-4725.1998.tb04223.x","article-title":"Skin resurfacing of the face with the Erbium:YAG laser","volume":"24","author":"Perez","year":"1998","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD013452-BIB0030|cit30","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD013452-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2133.2007.08267.x","article-title":"Pathology and pathobiology of actinic (solar) keratosis - an update","volume":"157","author":"Roewert-Huber","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"9","key":"10.1002\/14651858.CD013452-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-4632.2007.03166.x","article-title":"Actinic keratosis","volume":"46","author":"Rossi","year":"2007","journal-title":"International Journal of Dermatology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD013452-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2133.2007.07860.x","article-title":"Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification","volume":"156","author":"R\u00f6wert-Huber","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD013452-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1067\/mjd.2000.103342","article-title":"Epidemiology of actinic keratoses and squamous cell carcinoma","volume":"42","author":"Salasche","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD013452-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1067\/mjd.2000.107808","article-title":"Immunomodulatory and pharmacologic properties of imiquimod","volume":"43","author":"Sauder","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD013452-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.clindermatol.2013.05.007","article-title":"Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies","volume":"31","author":"Schmitt","year":"2013","journal-title":"Clinical Dermatolgoy"},{"issue":"5","key":"10.1002\/14651858.CD013452-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/jdv.14512","article-title":"Actinic keratoses show variable histological basal growth patterns - a proposed classification adjustment","volume":"32","author":"Schmitz","year":"2018","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD013452-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0190-9622(96)90329-1","article-title":"Premalignant keratinocytic neoplasms","volume":"35","author":"Schwartz","year":"1996","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD013452-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1524-4725.1997.tb00438.x","article-title":"The actinic keratosis: a perspective and update","volume":"23","author":"Schwartz","year":"1997","journal-title":"Dermatologic Surgery"},{"issue":"2","key":"10.1002\/14651858.CD013452-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.14852","article-title":"Current perspective on actinic keratosis: a review","volume":"177","author":"Siegel","year":"2017","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD013452-BIB0041|cit41","first-page":"156","article-title":"Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp","volume":"5","author":"Smith","year":"2006","journal-title":"Journal Drugs Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD013452-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1751-1097.2007.00276.x","article-title":"Photodynamic therapy in the treatment of actinic keratosis","volume":"84","author":"Stritt","year":"2008","journal-title":"Photochemistry and Photobiology"},{"issue":"10","key":"10.1002\/14651858.CD013452-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1001\/archderm.135.10.1177","article-title":"A systematic review of treatment modalities for primary basal cell carcinomas","volume":"135","author":"Thissen","year":"1999","journal-title":"Archives of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD013452-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"e96829","DOI":"10.1371\/journal.pone.0096829","article-title":"A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe","volume":"9","author":"Vegter","year":"2014","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1002\/14651858.CD013452-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjd.12420","article-title":"The natural history of actinic keratosis: a systematic review","volume":"169","author":"Werner","year":"2013","journal-title":"British Journal of Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD013452-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/jdv.13180","article-title":"Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version","volume":"29","author":"Werner","year":"2015","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"9","key":"10.1002\/14651858.CD013452-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1365-4632.2012.05776.x","article-title":"Understanding efficacy end-points in studies of field-directed therapy for actinic keratosis","volume":"52","author":"Wolf","year":"2013","journal-title":"International Journal of Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD013452-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004415.pub2","article-title":"Interventions for actinic keratoses","author":"Gupta","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD013452\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T23:17:55Z","timestamp":1628551075000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD013452"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":48,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013452","relation":{},"ISSN":["1465-1858"],"issn-type":[{"type":"electronic","value":"1465-1858"}],"subject":[],"published":{"date-parts":[[2019,10,22]]}}}